We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Compugen Announces $15 Million Funding Agreement for its Keddem Subsidiary

News   Mar 21, 2013

 
Compugen Announces $15 Million Funding Agreement for its Keddem Subsidiary
 
 
Advertisement
 

RELATED ARTICLES

Prevalence of Coronavirus Antibodies Declining in England

News

Tests on more than 365,000 people in England have shown that the antibody response to the virus that causes COVID-19 wanes over time.

READ MORE

Adaptate Biotherapeutics Appoints Stewart Kay as Chief Business Officer

News

Adaptate Biotherapeutics (Adaptate) today announced the appointment of Stewart Kay as Chief Business Officer (CBO).

READ MORE

Plant Compound Improves Cognition and Memory in Model of Down Syndrome

News

The plant compound apigenin improved the cognitive and memory deficits usually seen in a mouse model of Down syndrome, according to a study by researchers at the National Institutes of Health and other institutions.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE